MarkAndrewLewisMD

PubMed

• 1214 citations
  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
  Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
  Lancet. 2020-06-20
• 35 citations
  Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial
  Aneel Bhangu, Dmitri Nepogodiev, Natalie Ives, Laura Magill, James Glasbey
  Lancet. 2020-02-08
• 3 citations
  It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1
  Aditya S. Shirali, Carolina R.C. Pieterman, Mark A. Lewis, Samuel M. Hyde, Shalini Makawita
  CA. 2021-06-01

Journal Articles

• Treatment of Neuroendocrine Liver Metastases.  
  Lewis MA, Hobday TJ, International Journal of Hepatology. 2012: 973946
• Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma.  
  Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA, Journal of Clinical Oncology
• Treatment of Liver-Limited Disease from Colorectal Cancer.  
  Lewis MA, Hubbard J, Interventional Oncology
• Diagnosis: Nerves or Something Worse?  
  Sanders L, New York Times. Magazine
• Intravascular Mucinosis, a Rare Cause of Cerebral Infarction.  
  Bernardo MC, Radford JG, Menke J, Hallemeier C, Boes CJ, Lewis M, Scheithauer B, Giannini C, Acta Neuropathologica; 121(6):785-8
• Talactoferrin Immunotherapy in Metastatic Renal Cell Carcinoma: A Case Series of Four Long-Term Survivors.  
  Lewis M, Hayes T, Journal of Clinical Medicine Research;3(1):47-51
• Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer.  
  Lewis M, Hartmann L, LaChance D, Jimenez R, Rare Tumors 2(3):e42
• Ockham’s Razor Is Not So Sharp.  
  Lewis M, Agusala K, Raizen Y, Infectious Disease Reports. Vol. 2, No. 2
• Join now to see all

Abstracts/Posters

• Cutaneous Vasculitis Associated with All-Trans Retinoic Acid (ATRA) Therapy for Acute Promyelocytic Leukemia.
  Storan E, Lewis MA, Al-Kali A, European Academy of Dermatology and Venereology Annual Meeting
• Post-recurrence survival in patients with previously resected esophageal adenocarcinoma (EAC).
  Lewis MA, Yoon HH, Shi Q, Diasio RB, Sinicrope FA, ASCO Annual Meeting. Abstract #95558
• Preoperative Assessment of the MEN 1 Pancreas.
  Lewis M, Young WF, Thompson GB, World Journal of Surgery 35: 2011 (suppl 1; abstr 0895)
• Association of body mass index (BMI) with smoking and prognosis in 721 patients with esophagogastric adenocarcinoma.
  Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope F, Yoon HH, 2011 ASCO Annual Meeting. Journal of Clinical Oncology 29
• Hospitalization after hepatic artery embolization (HAE) for neuroendocrine tumors (NET).
  Jaramillo S, Lewis MA, Roberts LR, Rubin J, Grothey A, 2011 ASCO Annual Meeting. Journal of Clinical Oncology 29
• 8p11.12 Myeloproliferative Syndrome: A Case Report & Brief Review of the Literature.
  Yellapragada S, Mims M, Jackson C, Lewis MA, Udden M, 2008 ASH Annual Meeting. Blood (ASH Annual Meeting Abstracts)
• Join now to see all

Lectures

• Talactoferrin as a novel therapeutic agent in metastatic renal cell carcinoma. 
  2007 Texas Society of Medical Oncology meeting, Houston, Texas
• Oral talactoferrin (recombinant human lactoferrin) as a novel therapeutic agent in metastatic renal cell carcinoma. 
  2nd place in Clinical Research at 2008 Baylor College of Medicine Housestaff Research Symposium, TX